Indiana § 12-23-18-7 - Adoption of rules establishing standards and protocols; use of alternative medication for treatment; explanation of side effects
Full text of Indiana Indiana Code § 12-23-18-7 — Adoption of rules establishing standards and protocols; use of alternative medication for treatment; explanation of side effects, with citation guidance and answers to common questions.
§ 12-23-18-7. Adoption of rules establishing standards and protocols; use of alternative medication for treatment; explanation of side effects
Sec. 7. (a) The division shall adopt rules under IC 4-22-2 to establish standards and protocols for opioid treatment programs to do the following:
(1) Assess new opioid treatment program patients to determine the most effective opioid treatment medications to start the patient's opioid treatment.
(2) Ensure that each patient voluntarily chooses maintenance treatment and that relevant facts concerning the use of opioid treatment medications are clearly and adequately explained to the patient.
(3) Have appropriate opioid treatment program patients who are receiving methadone for opioid treatment move to receiving other approved opioid treatment medications.
(b) An opioid treatment program shall follow the standards and protocols adopted under subsection (a) for each opioid treatment program patient.
(c) Subject to subsection (a), an opioid treatment program may use any of the following medications as an alternative for methadone for opioid treatment:
(1) Buprenorphine.
(2) Buprenorphine combination products containing naloxone.
(3) Naltrexone injectable and extended release.
(4) A federal Food and Drug Administration approved long acting, nonaddictive medication for the treatment of opioid or alcohol dependence.
(5) Any other medication that has been approved by:
(A) the federal Food and Drug Administration for use in the treatment of opioid addiction; and
(B) the division under subsection (e).
(d) Before starting a patient on a new opioid treatment medication, the opioid treatment program shall explain to the patient the potential side effects of the new medication.
(e) The division may adopt rules under IC 4-22-2 to provide for other medications, including a federal Food and Drug Administration approved long acting, nonaddictive medication for the treatment of opioid or alcohol dependence, as alternatives to methadone that may be used under subsection (a).
As added by P.L.131-2014, SEC.4. Amended by P.L.187-2015, SEC.21; P.L.209-2015, SEC.15.
Source: official Indiana text · Last verified 2026-08-27
Frequently Asked Questions About Indiana § 12-23-18-7
What does Indiana Code § 12-23-18-7 cover?
Section 12-23-18-7 ("Adoption of rules establishing standards and protocols; use of alternative medication for treatment; explanation of side effects") is part of the Indiana Code, the codified statutory law of Indiana. It sets out the legal rule or procedure described in the text above. Statutes are amended regularly, so always verify against the official source.
How do I cite Indiana § 12-23-18-7?
A common citation format is "Indiana Code § 12-23-18-7" (Indiana). Legal writing may require the code abbreviation, section number, and year or edition. Match the style required by your court, professor, or publisher.
Is this the official text of Indiana law?
No. This page is for research and education and may not include the most recent amendments. For official current law, check the Indiana official source linked on this page or consult a licensed Indiana attorney.
How does Indiana § 12-23-18-7 apply to my situation?
Statutes are interpreted in context, and application depends on your specific facts. Only a licensed attorney in Indiana can advise on how this section applies to you. Contact your state or local bar association for a referral.
Sources & Verification
Not legal advice. Verify against the official source and consult a licensed attorney in Indiana.